Published in FEBS J on October 31, 2011
The spliceosome as a target of novel antitumour drugs. Nat Rev Drug Discov (2012) 2.51
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood (2015) 1.75
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Leukemia (2012) 1.31
Myeloid malignancies: mutations, models and management. BMC Cancer (2012) 1.24
The development and application of small molecule modulators of SF3b as therapeutic agents for cancer. Drug Discov Today (2012) 1.10
Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43. J Nat Prod (2013) 1.00
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nat Med (2016) 0.97
Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs. J Biol Chem (2013) 0.97
Enantioselective total synthesis of pladienolide B: a potent spliceosome inhibitor. Org Lett (2012) 0.95
RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer (2016) 0.92
NAMPT is the cellular target of STF-31-like small-molecule probes. ACS Chem Biol (2014) 0.90
Identification of small molecule inhibitors of pre-mRNA splicing. J Biol Chem (2014) 0.87
Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B. Haematologica (2015) 0.87
Structure of FD-895 revealed through total synthesis. Org Lett (2012) 0.86
Therapeutic targeting of splicing in cancer. Nat Med (2016) 0.85
Stabilized cyclopropane analogs of the splicing inhibitor FD-895. J Med Chem (2013) 0.84
High antitumor activity of pladienolide B and its derivative in gastric cancer. Cancer Sci (2013) 0.82
Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival. Oncotarget (2016) 0.81
Splicing inhibition decreases phosphorylation level of Ser2 in Pol II CTD. Nucleic Acids Res (2015) 0.81
Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia. Oncotarget (2012) 0.80
Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis. BMC Cancer (2015) 0.78
Modulating splicing with small molecular inhibitors of the spliceosome. Wiley Interdiscip Rev RNA (2016) 0.77
Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment. Biomed Res Int (2016) 0.75
Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1). Sci Rep (2017) 0.75
Splicing factor gene mutations in hematologic malignancies. Blood (2016) 0.75
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma. Cell Rep (2016) 0.75
Ruthenium-Catalyzed Olefin Metathesis after Tetra-n-butylammonium Fluoride-Mediated Desilylation. Tetrahedron Lett (2012) 0.75
Identification of hub genes of pneumocyte senescence induced by thoracic irradiation using weighted gene co‑expression network analysis. Mol Med Rep (2015) 0.75
Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol (2007) 3.97
Impact of plaque morphology on creatine kinase-MB elevation in patients with elective stent implantation. Int J Cardiol (2010) 2.05
Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood (2010) 1.78
Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards. Nat Biotechnol (2005) 1.76
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities. J Antibiot (Tokyo) (2004) 1.74
A cDNA resource from the basal chordate Ciona intestinalis. Genesis (2002) 1.65
Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation. JACC Cardiovasc Interv (2011) 1.44
A case of quadruplet pregnancy with a complete hydatidiform mole. Prenat Diagn (2005) 1.38
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma. Mol Cancer Ther (2014) 1.37
Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. J Cell Biol (2006) 1.36
Ultrasound can improve the accuracy of the 2010 American College of Rheumatology/European League against rheumatism classification criteria for rheumatoid arthritis to predict the requirement for methotrexate treatment. Arthritis Rheum (2013) 1.28
Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models. Cancer Lett (2013) 1.22
Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma. J Cancer Res Clin Oncol (2008) 1.19
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. I. Taxonomy, fermentation, isolation and screening. J Antibiot (Tokyo) (2004) 1.17
Genomic overview of mRNA 5'-leader trans-splicing in the ascidian Ciona intestinalis. Nucleic Acids Res (2006) 1.16
Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors. Clin Cancer Res (2013) 1.14
Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. Gastroenterology (2006) 1.13
A Rac GTPase-activating protein, MgcRacGAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors. Mol Cell Biol (2009) 1.12
In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography. Eur Heart J (2011) 1.09
Chromosomal mapping of 170 BAC clones in the ascidian Ciona intestinalis. Genome Res (2005) 1.09
Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling. J Natl Cancer Inst (2009) 1.07
Total synthesis of the potent antitumor macrolides pladienolide B and D. Angew Chem Int Ed Engl (2007) 1.07
Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis. Proc Natl Acad Sci U S A (2005) 1.06
Adam22 is a major neuronal receptor for Lgi4-mediated Schwann cell signaling. J Neurosci (2010) 1.06
Nitric oxide-dependent modulation of the delayed rectifier K+ current and the L-type Ca2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes. Br J Pharmacol (2004) 1.05
Mutations in the COCH gene are a frequent cause of autosomal dominant progressive cochleo-vestibular dysfunction, but not of Meniere's disease. Eur J Hum Genet (2003) 1.05
Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal cell wall assembly. Mol Microbiol (2003) 1.05
Side population cells contribute to the genesis of human endometrium. Fertil Steril (2008) 1.03
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. II. Physico-chemical properties and structure elucidation. J Antibiot (Tokyo) (2004) 1.03
Assessment of acute injuries and chronic intimal thickening of the radial artery after transradial coronary intervention by optical coherence tomography. Eur Heart J (2010) 1.02
GWT1 gene is required for inositol acylation of glycosylphosphatidylinositol anchors in yeast. J Biol Chem (2003) 1.01
Prediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual synovial inflammation before discontinuation. Arthritis Care Res (Hoboken) (2014) 1.00
Effect of micro-environment maintenance on embryo culture after in-vitro fertilization: comparison of top-load mini incubator and conventional front-load incubator. J Assist Reprod Genet (2006) 1.00
MR imaging of diffuse adenomyosis changes after GnRH analog therapy. J Magn Reson Imaging (2002) 1.00
Stereochemistry of pladienolide B. J Antibiot (Tokyo) (2007) 0.98
A GTPase-activating protein binds STAT3 and is required for IL-6-induced STAT3 activation and for differentiation of a leukemic cell line. Blood (2004) 0.98
Exaggerated placental site, consisting of implantation site intermediate trophoblasts, causes massive postpartum uterine hemorrhage: case report and literature review. Tohoku J Exp Med (2014) 0.96
Mass++: A Visualization and Analysis Tool for Mass Spectrometry. J Proteome Res (2014) 0.93
Maternal thyroid function during pregnancy and puerperal period. Endocr J (2005) 0.92
Subarachnoid hemorrhage in systemic lupus erythematosus in Japan: two case reports and a review of the literature. Mod Rheumatol (2009) 0.92
Deficits in spatial learning and motor coordination in ADAM11-deficient mice. BMC Neurosci (2006) 0.92
E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis. Antimicrob Agents Chemother (2011) 0.91
Lgi4 promotes the proliferation and differentiation of glial lineage cells throughout the developing peripheral nervous system. J Neurosci (2010) 0.91
Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul Pept (2006) 0.90
Roles of CRTH2+ CD4+ T cells in immunoglobulin G4-related lacrimal gland enlargement. Int Arch Allergy Immunol (2012) 0.89
The spatial and temporal expression of delta-like protein 1 in the rat pituitary gland during development. Histochem Cell Biol (2008) 0.88
Roles of IL-22 in Allergic Airway Inflammation. J Allergy (Cairo) (2013) 0.88
Glucose intolerance in Japanese patients with polycystic ovary syndrome. Arch Gynecol Obstet (2006) 0.88
Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standards. Anal Chem (2009) 0.86
Intravenous administration of ghrelin stimulates growth hormone secretion in vagotomized patients as well as normal subjects. Eur J Endocrinol (2004) 0.86
Dectin-2 promotes house dust mite-induced T helper type 2 and type 17 cell differentiation and allergic airway inflammation in mice. Am J Respir Cell Mol Biol (2014) 0.86
β-glucan curdlan induces IL-10-producing CD4+ T cells and inhibits allergic airway inflammation. J Immunol (2012) 0.86
[18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis. Rheumatology (Oxford) (2013) 0.85
Pregnancy-associated changes in genome-wide gene expression profiles in the liver of cow throughout pregnancy. Biochem Biophys Res Commun (2004) 0.85
Role of N-cadherin in the regulation of hematopoietic stem cells in the bone marrow niche. Ann N Y Acad Sci (2012) 0.85
Genome-wide network of regulatory genes for construction of a chordate embryo. Dev Biol (2008) 0.84
An ultrasensitive new DNA microarray chip provides gene expression profiles for preoperative esophageal cancer biopsies without RNA amplification. Oncology (2008) 0.84
Successful pregnancy after gonadotropin-releasing hormone analogue and hysteroscopic myomectomy in a woman with diffuse uterine leiomyomatosis. Arch Gynecol Obstet (2008) 0.84
Effectiveness of antiadhesion barriers in preventing adhesion after myomectomy in patients with uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol (2005) 0.84
McCune-Albright syndrome with acromegaly and fibrous dysplasia associated with the GNAS gene mutation identified by sensitive PNA-clamping method. Intern Med (2007) 0.83
BMP4 induces primitive endoderm but not trophectoderm in monkey embryonic stem cells. Cloning Stem Cells (2008) 0.83
Altered nociceptive response in ADAM11-deficient mice. Brain Res (2006) 0.83
High antitumor activity of pladienolide B and its derivative in gastric cancer. Cancer Sci (2013) 0.82
Differential regulation of pituitary hormone secretion and gene expression by thyrotropin-releasing hormone. A role for mitogen-activated protein kinase signaling cascade in rat pituitary GH3 cells. Biol Reprod (2002) 0.82
Expressions of cytochrome P450, UDP-glucuronosyltranferase, and transporter genes in monolayer carcinoma cells change in subcutaneous tumors grown as xenografts in immunodeficient nude mice. Drug Metab Dispos (2009) 0.81
MPR1 as a novel selection marker in Saccharomyces cerevisiae. Yeast (2009) 0.81
Neoadjuvant intraarterial chemotherapy for stage IIB-IIIB cervical cancer in Japanese women. Exp Ther Med (2010) 0.81
Mutational analysis of the PTEN gene in women with premature ovarian failure. Acta Obstet Gynecol Scand (2009) 0.81
Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor. Int J Mol Med (2011) 0.80
Markers for step-down of inhaled corticosteroid therapy in adult asthmatics. Allergol Int (2012) 0.79
High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers. Cancer Sci (2006) 0.79
Primate model research for endometriosis. Tohoku J Exp Med (2012) 0.79
MRI evaluation of the uterine structure after myomectomy. Gynecol Obstet Invest (2005) 0.79
Subpopulations of macrophages within eutopic endometrium of endometriosis patients. Am J Reprod Immunol (2014) 0.78
Novel ATP-competitive MEK inhibitor E6201 is effective against vemurafenib-resistant melanoma harboring the MEK1-C121S mutation in a preclinical model. Mol Cancer Ther (2014) 0.78
Total synthesis of 6-deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 cancer cell line. Org Lett (2014) 0.78
[Prognosis of type A acute aortic dissection treated conservatively]. Kyobu Geka (2010) 0.78
In silico approach to identify the expression of the undiscovered molecules from microarray public database: identification of odorant receptors expressed in non-olfactory tissues. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.78
Long-term outcome, including pregnancy rate, recurrence rate and ovarian reserve, after laparoscopic laser ablation surgery in infertile women with endometrioma. J Obstet Gynaecol Res (2010) 0.77
Genomic structure, expression, and transcriptional regulation of human Gal beta 1,3 GalNAc alpha 2,3-sialyltransferase gene. Biochem Biophys Res Commun (2003) 0.77
Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist. Fertil Steril (2007) 0.77
Gene expression profile in experimental mesangial proliferative glomerulonephritis. J Pharmacol Sci (2004) 0.77
Small molecule schweinfurthins selectively inhibit cancer cell proliferation and mTOR/AKT signaling by interfering with trans-Golgi-network trafficking. Cancer Biol Ther (2015) 0.77
Regulation of gonadotropin alpha subunit gene expression by dopamine D(2) receptor agonist in clonal mouse gonadotroph alphaT3-1 cells. Biol Reprod (2002) 0.77
A novel carbazole topoisomerase II poison, ER-37328: potent tumoricidal activity against human solid tumors in vitro and in vivo. Cancer Sci (2003) 0.76
Interleukin-25 induces pulmonary arterial remodeling via natural killer T cell-dependent mechanisms. Int Arch Allergy Immunol (2013) 0.76
Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor. Mol Cancer Ther (2002) 0.76
Developmental aberrations of liver gene expression in bovine fetuses derived from somatic cell nuclear transplantation. Cloning Stem Cells (2006) 0.76
Hemorrhagic ovarian cyst without peritoneal bleeding in a patient with ovarian hyperstimulation syndrome: case report. Chin Med J (Engl) (2005) 0.76
Early zygotic expression of transcription factors and signal molecules in fully dissociated embryonic cells of Ciona intestinalis: A microarray analysis. Dev Growth Differ (2009) 0.76
Expression and activation of mitogen-activated protein kinase in the human endometrium during the menstrual cycle. Am J Obstet Gynecol (2006) 0.76
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma. PLoS One (2017) 0.75